Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-16 9:35 pm Purchase |
2024-09-12 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 10,742,993 19.990% |
149,598 (+1.41%) |
Filing History |
| 2024-09-16 8:21 pm Purchase |
2024-09-12 | 13G | Fulcrum Therapeutics, Inc. FULC |
RA Capital Management, L.P. | 10,229,099 19.300% |
4,684,883 (+84.50%) |
Filing History |
| 2024-09-03 4:18 pm Unchanged |
2024-08-29 | 13D | Artiva Biotherapeutics, Inc. ARTV |
RA Capital Management, L.P. | 9,853,302 40.600% |
0 (Unchanged) |
Filing History |
| 2024-08-23 4:16 pm Purchase |
2024-08-13 | 13G | Avalo Therapeutics, Inc. AVTX |
RA Capital Management, L.P. | 967,299 9.990% |
967,299 (New Position) |
Filing History |
| 2024-08-23 4:16 pm Sale |
2024-08-21 | 13G | Fulcrum Therapeutics, Inc. FULC |
RA Capital Management, L.P. | 5,544,216 9.990% |
-6,065,488 (-52.24%) |
Filing History |
| 2024-08-13 5:40 pm Sale |
2024-08-09 | 13G | AN2 Therapeutics, Inc. ANTX |
RA Capital Management, L.P. | 1,999,997 6.700% |
-3,551,298 (-63.97%) |
Filing History |
| 2024-08-12 4:22 pm Purchase |
2024-07-31 | 13G | Adagio Medical Holdings, Inc. ADGM |
RA Capital Management, L.P. | 1,337,813 9.990% |
1,337,813 (New Position) |
Filing History |
| 2024-08-07 5:51 pm Unchanged |
2024-08-05 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 14,254,298 13.400% |
0 (Unchanged) |
Filing History |
| 2024-07-29 4:29 pm Purchase |
2024-07-22 | 13D | Artiva Biotherapeutics, Inc. ARTV |
RA Capital Management, L.P. | 9,853,302 42.300% |
9,853,302 (New Position) |
Filing History |
| 2024-07-25 4:16 pm Purchase |
2024-07-18 | 13D | Cidara Therapeutics, Inc. CDTX |
RA Capital Management, L.P. | 703,080 9.990% |
703,080 (New Position) |
Filing History |
| 2024-07-08 4:17 pm Purchase |
2024-06-28 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
RA Capital Management, L.P. | 15,384,615 5.900% |
15,384,615 (New Position) |
Filing History |
| 2024-07-01 9:31 pm Purchase |
2024-06-21 | 13G | Praxis Precision Medicines, Inc. PRAX |
RA Capital Management, L.P. | 1,235,599 7.200% |
1,235,599 (New Position) |
Filing History |
| 2024-07-01 9:28 pm Purchase |
2024-06-27 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 31,459,267 47.100% |
18,268,418 (+138.49%) |
Filing History |
| 2024-06-24 5:06 pm Purchase |
2024-06-13 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC |
RA Capital Management, L.P. | 750,000 8.400% |
750,000 (New Position) |
Filing History |
| 2024-06-20 6:00 pm Purchase |
2024-06-17 | 13D | Aerovate Therapeutics, Inc. AVTE |
RA Capital Management, L.P. | 9,242,092 32.000% |
928,110 (+11.16%) |
Filing History |
| 2024-06-17 8:50 pm Purchase |
2024-06-06 | 13G | Evolent Health, Inc. EVH |
RA Capital Management, L.P. | 8,279,103 7.100% |
8,279,103 (New Position) |
Filing History |
| 2024-06-12 6:26 pm Purchase |
2024-06-11 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 4,358,478 11.300% |
9,650 (+0.22%) |
Filing History |
| 2024-06-07 4:18 pm Purchase |
2024-05-28 | 13G | Bicycle Therapeutics plc BCYC |
RA Capital Management, L.P. | 2,253,000 5.000% |
2,253,000 (New Position) |
Filing History |
| 2024-06-06 4:16 pm Purchase |
2024-06-04 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 13,190,849 44.300% |
557 (+0.00%) |
Filing History |
| 2024-06-03 8:53 pm Purchase |
2024-05-23 | 13G | Tourmaline Bio, Inc. TRML |
RA Capital Management, L.P. | 2,045,028 8.000% |
2,045,028 (New Position) |
Filing History |